Analytical Procedures and Methods Validation for Drugs and Biologics
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 27, 2015
April 21, 2020
b63babeb-6796-4e5d-a992-7830e31b2f5a
Related Documents
Scientific Considerations in Demonstrating Biosimilarity to a Reference Product
Guidance DocumentApril 28, 2015Center for Drug Evaluation and Research
Bispecific Antibody Development Programs Guidance for Industry
Guidance DocumentMay 24, 2021Center for Drug Evaluation and Research
Advanced Manufacturing Technologies Designation Program
Guidance DocumentDecember 31, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox